Suppressed fever and hypersensitivity responses in chicks prenatally exposed to opiates.
We have established procedures to reliably induce opiate dependence in the chick embryo via in ovo injection, early in embryonic development, of the long-acting and potent opiate N-desmethyl-l-alpha-noracetylmethadol (NLAAM). Prior studies found that there is continual exposure to NLAAM throughout embryogenesis and shortly after hatching there are signs of spontaneous withdrawal. In the present study, we used three doses of NLAAM (2.5, 5, and 10 mg/kg egg weight) to determine if prenatal opiate exposure followed by postnatal withdrawal interfered with appropriate neural-endocrine-immune interactions in the young chick. To ensure that effects were not a consequence of inappropriately large doses, we first examined acute and chronic toxicity and additional characteristics of postnatal opiate withdrawal. We then measured the corticosterone and fever responses to LPS stimulation during the withdrawal period. After the conclusion of opiate withdrawal, we assessed the hypersensitivity response to phytohemagglutinin (PHA). The fever response to LPS and the hypersensitivity response to PHA were suppressed by prenatal opiate exposure and postnatal withdrawal. The corticosterone response to LPS was not affected, but there were exaggerated corticosterone responses to saline injection in chicks exposed in ovo to NLAAM. It was unlikely that the effects of prenatal NLAAM were the result of toxicity, as little chronic toxicity was seen with the lower two doses of NLAAM, doses that yielded significant suppressions of neural-endocrine-immune responses. However, effects found in the chicks treated with 10 mg NLAAM/kg may have been partly related to the greater toxicity and/or protracted postnatal withdrawal in this group.
Department of Pharmacology and Therapeutics, Louisiana State University Health Sciences Center, 1501 Kings Highway, P.O. Box 33932, Shreveport, LA 71130-3932, USA. lschro@lsuhsc.edu
Lisa M
LM
Schrott
Sheldon B
SB
Sparber
D000704:Analysis of Variance; D000818:Animals; D001491:Basophils / Q000187:drug effects / Q000276:immunology; D002642:Chick Embryo; D002645:Chickens; D003345:Corticosterone / Q000097:blood; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D047108:Embryonic Development / Q000187:drug effects; D005260:Female; D005334:Fever / Q000139:chemically induced / Q000276:immunology*; D006967:Hypersensitivity / Q000276:immunology*; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects / Q000196:embryology / Q000503:physiopathology*; D008070:Lipopolysaccharides; D008692:Methadyl Acetate / Q000031:analogs & derivatives* / Q000633:toxicity*; D009294:Narcotics / Q000633:toxicity; D015213:Neuroimmunomodulation / Q000187:drug effects*; D010063:Ovum; D012867:Skin / Q000276:immunology; D013375:Substance Withdrawal Syndrome / Q000276:immunology / Q000503:physiopathology*; D023382:Toxicity Tests, Acute; D036401:Toxicity Tests, Chronic
D008070:Lipopolysaccharides; D009294:Narcotics; C020783:paracymethadol; D008692:Methadyl Acetate; D003345:Corticosterone